PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
27-Apr-2020 Six COVID-19 Patients Treated with RedHill’s Opaganib Under Compassionate Use Show Objective Clinical Improvement RedHill Biopharma
27-Apr-2020 Phase 3 trial of Libtayo® (cemiplimab) as monotherapy for first-line advanced non-small cell lung cancer stopped early due to highly significant improvement in overall survival Sanofi
27-Apr-2020 Sanofi and Regeneron provide update on U.S. Phase 2/3 adaptive-designed trial in hospitalized COVID-19 patients Sanofi
27-Apr-2020 ARTES Joins Global Combat against Corona ARTES Biotechnology
27-Apr-2020 Valo Therapeutics to Support Development of a Pan – Coronavirus Vaccine Valo Therapeutics
27-Apr-2020 Lokelma US label updated to include dosing guidance for the treatment of hyperkalaemia in patients with end-stage renal disease on haemodialysis Label update is based on data from Phase IIIb DIALIZE trial AstraZeneca
27-Apr-2020 Mental health care company COMPASS Pathways concludes successful Series B investment round $80m raised will further the development of psilocybin therapy COMPASS Pathways
27-Apr-2020 Research into medicinal cannabis for treatment of coronavirus ANANDA DEVELOPMENTS PLC
27-Apr-2020 MDxHealth Announces Growth Investment from MVM Partners MDxHealth SA
27-Apr-2020 Development of rapid, point of care, immunodiagnostic test for detection of the SARS-CoV-2 (COVID-19) Leinco Technologies
27-Apr-2020 Santhera and Cold Spring Harbor Laboratory to Investigate Lonodelestat (POL6014) in COVID-19-related Acute Respiratory Distress Syndrome (ARDS) Santhera Pharmaceuticals
27-Apr-2020 ATAI Life Sciences announces close of $24 million convertible note financing round and welcomes Jason Camm of Thiel Capital to Board of Directors ATAI Life Sciences
27-Apr-2020 NanoPass Is Joining Forces with Pharma Partners in The Fight Against The COVID-19 Pandemic NanoPass
24-Apr-2020 Medidata Accelerates Launch of myMedidata Platform, Responding to COVID-19 Medidata
24-Apr-2020 Flowchem firm joins fight against Coronavirus Flowchem
24-Apr-2020 FDA approves MenQuadfiTM, the latest innovation in meningococcal (MenACWY) vaccination Sanofi
24-Apr-2020 Almac Group increases volume of essential clinical supplies to patients in their homes Almac Group
24-Apr-2020 Pharnext and the University Hospital Institute Méditérranée Infection Announce a Joint Effort to Evaluate Repurposed Drugs for Potential Use Against the COVID-19 Virus Pharnext
24-Apr-2020 Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting Santhera Pharmaceuticals
24-Apr-2020 Cegedim Supporting Patient Care during COVID-19 Cegedim